5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Mon, 08/02/2010 - 10:30
Carboplatin and Paclitaxel as Therapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Thu, 07/29/2010 - 13:08
Year in Review – Gastrointestinal Cancers: 2009-2010
Submitted by web@researchtop... on Thu, 07/29/2010 - 10:05
Year in Review – Gastrointestinal Cancers: 2009-2010 |
|---|
Effect of Early Palliative Care on End-of-Life Care Outcomes among Patients with Metastatic NSCLC
Submitted by web@researchtop... on Tue, 07/27/2010 - 17:02
NCIC CTG BR.19: Gefitinib Therapy for Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 16:59
First-Line Erlotinib with or without Chemotherapy for Never or Light Smokers with Advanced Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 16:56
First-in-Human Study of the Oral ALK Inhibitor Crizotinib for Patients with ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Tue, 07/27/2010 - 16:52
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Tue, 07/27/2010 - 15:46
Safety and Efficacy of Bosutinib in Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After Resistance or Intolerance to Imatinib
Submitted by web@researchtop... on Fri, 07/23/2010 - 09:16
Update of the ENESTnd Study: Comparison of Nilotinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)
Submitted by web@researchtop... on Fri, 07/23/2010 - 09:14
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP)
Submitted by web@researchtop... on Fri, 07/23/2010 - 09:10
5-Minute Journal Club — ASCO 2010 Presentations
Submitted by web@researchtop... on Fri, 07/23/2010 - 08:37
Atlas of Molecular Oncology - Critical Pathways in Breast Cancer Treatment
Submitted by web@researchtop... on Thu, 07/22/2010 - 17:13
Eribulin versus Treatment of Physician’s Choice for Patients with Heavily Pretreated Advanced Breast Cancer
Submitted by jwr@option4.com on Sat, 07/17/2010 - 20:11
Activity of Bevacizumab in Combination with First- and Second-Line Chemotherapy for Metastatic Breast Cancer (mBC)
Submitted by jwr@option4.com on Sat, 07/17/2010 - 20:09